Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Enhancement of proteasome function by PA28α overexpression protects against oxidative stress.

Li J, Powell SR, Wang X.

FASEB J. 2011 Mar;25(3):883-93. doi: 10.1096/fj.10-160895.

2.

Enhancement of proteasomal function protects against cardiac proteinopathy and ischemia/reperfusion injury in mice.

Li J, Horak KM, Su H, Sanbe A, Robbins J, Wang X.

J Clin Invest. 2011 Sep;121(9):3689-700. doi: 10.1172/JCI45709.

3.

Protein kinase g positively regulates proteasome-mediated degradation of misfolded proteins.

Ranek MJ, Terpstra EJ, Li J, Kass DA, Wang X.

Circulation. 2013 Jul 23;128(4):365-76. doi: 10.1161/CIRCULATIONAHA.113.001971.

4.

The proteasome regulator PA28alpha/beta can enhance antigen presentation without affecting 20S proteasome subunit composition.

Schwarz K, Eggers M, Soza A, Koszinowski UH, Kloetzel PM, Groettrup M.

Eur J Immunol. 2000 Dec;30(12):3672-9.

PMID:
11169410
5.

Nitric oxide decreases activity and levels of the 11S proteasome activator PA28 in the vasculature.

Tsihlis ND, Kapadia MR, Vavra AK, Jiang Q, Fu B, Martinez J, Kibbe MR.

Nitric Oxide. 2012 Jun 30;27(1):50-8. doi: 10.1016/j.niox.2012.04.006.

PMID:
22561112
6.

Anti-20S proteasome autoantibodies inhibit proteasome stimulation by proteasome activator PA28.

Brychcy M, Kuckelkorn U, Hausdorf G, Egerer K, Kloetzel PM, Burmester GR, Feist E.

Arthritis Rheum. 2006 Jul;54(7):2175-83. Erratum in: Arthritis Rheum. 2006 Aug;54(8):2702.

7.

The proteasome subunit, C2, contains an important site for binding of the PA28 (11S) activator.

Kania MA, Demartino GN, Baumeister W, Goldberg AL.

Eur J Biochem. 1996 Mar 1;236(2):510-6.

8.

Phosphorylation of the proteasome activator PA28 is required for proteasome activation.

Li N, Lerea KM, Etlinger JD.

Biochem Biophys Res Commun. 1996 Aug 23;225(3):855-60.

PMID:
8780702
9.
10.
11.

Structural and functional properties of proteasome activator PA28.

Kuehn L, Dahlmann B.

Mol Biol Rep. 1997 Mar;24(1-2):89-93. Review.

PMID:
9228287
12.

Properties of the beta subunit of the proteasome activator PA28 (11S REG).

Wilk S, Chen WE, Magnusson RP.

Arch Biochem Biophys. 2000 Dec 1;384(1):174-80.

PMID:
11147828
13.

Muscarinic 2 receptors modulate cardiac proteasome function in a protein kinase G-dependent manner.

Ranek MJ, Kost CK Jr, Hu C, Martin DS, Wang X.

J Mol Cell Cardiol. 2014 Apr;69:43-51. doi: 10.1016/j.yjmcc.2014.01.017.

14.

Allele-selective effect of PA28 in MHC class I antigen processing.

Yamano T, Sugahara H, Mizukami S, Murata S, Chiba T, Tanaka K, Yui K, Udono H.

J Immunol. 2008 Aug 1;181(3):1655-64.

15.

Regulation of proteasome-mediated protein degradation during oxidative stress and aging.

Breusing N, Grune T.

Biol Chem. 2008 Mar;389(3):203-9. doi: 10.1515/BC.2008.029. Review.

PMID:
18208355
16.

In vivo characterization of the proteasome regulator PA28.

Ahn K, Erlander M, Leturcq D, Peterson PA, Früh K, Yang Y.

J Biol Chem. 1996 Jul 26;271(30):18237-42.

18.

The immunoproteasome, the 20S proteasome and the PA28αβ proteasome regulator are oxidative-stress-adaptive proteolytic complexes.

Pickering AM, Koop AL, Teoh CY, Ermak G, Grune T, Davies KJ.

Biochem J. 2010 Dec 15;432(3):585-94. doi: 10.1042/BJ20100878.

19.

Kinetic evidences for facilitation of peptide channelling by the proteasome activator PA28.

Stohwasser R, Salzmann U, Giesebrecht J, Kloetzel PM, Holzhütter HG.

Eur J Biochem. 2000 Oct;267(20):6221-30.

20.

Removal of damaged proteins during ES cell fate specification requires the proteasome activator PA28.

Hernebring M, Fredriksson Å, Liljevald M, Cvijovic M, Norrman K, Wiseman J, Semb H, Nyström T.

Sci Rep. 2013;3:1381. doi: 10.1038/srep01381.

Items per page

Supplemental Content

Support Center